'Salvage therapy' diaporamas de présentation

Scope

Scope. The objective of this guideline is to aid clinicians in deciding: which patients with primary refractory or relapsed Hodgkin lymphoma (HL) should receive salvage therapy with a view to autologous stem cell transplantation ( ASCT)

811 views • 60 slides

CSS Istiocitosi

CSS Istiocitosi. Giornate AIEOP Verona 2006 . Aggiornamento studi: LCH-3. Studio in corso Arruolamento regolare su scala internazionale per i casi MS Mancata segnalazione dei casi meno gravi ! Mancata randomizzazione MS low risk Mancata registrazione MFB

847 views • 59 slides

The New Surviving Sepsis Bundles: From Time Zero to Tomorrow

The New Surviving Sepsis Bundles: From Time Zero to Tomorrow. R. Phillip Dellinger, MD, MCCM Mitchell M. Levy, MD, FCCM. Faculty. R. Phillip Dellinger, MD, MCCM Professor of Medicine Cooper Medical School of Rowan University Director, Critical Care Cooper University Hospital Camden, NJ

755 views • 44 slides

Transplantation in Low Grade Lymphomas

Transplantation in Low Grade Lymphomas. John G. Gribben, MD, DSc, FMedSci Professor of Experimental Cancer Medicine Barts and The London School of Medicine University of London United Kingdom.

534 views • 41 slides

Is there Long-Term Benefit from Maintenance Rituximab?

Is there Long-Term Benefit from Maintenance Rituximab?. Emanuele Zucca, MD Oncology Institute of Southern Switzerland (IOSI) Swiss Group for Clinical Cancer Research (SAKK). Rationale and aim of maintenance in haematological malignancies.

563 views • 37 slides

Meet The Professors Hodgkin Lymphoma 2018

Meet The Professors Hodgkin Lymphoma 2018. Hodgkin Lymphoma (HL) by the Numbers. Optimal Upfront Treatment 8700 pts. 700 Pts ?70 years No standard TX. Favorable ES. Unfavorable ES. Unfavorable ES with Bulk. Favorable AS. Unfavorable AS. 1000. 2500. 1000. 2500. 1000. 100 Fail.

803 views • 27 slides

1 Badoux XC et al. Proc ASH 2011;Abstract 980. 2 James DF et al. Proc ASH 2011;Abstract 291. 3 Egle A et al. Pro

262 views • 25 slides

Study Design

CPCRA GART Study (046) A Randomized Study of Antiretroviral Management Based on Plasma Genotypic Antiretroviral Resistance Testing (GART) in Patients Failing Antiretroviral Therapy. GART (N = 78). No-GART (N = 75). Follow-up Wks 4, 8, & 12. Follow-up Wks 4, 8, & 12. Study Design.

314 views • 20 slides

Case presentation 21 September 2012

Case presentation 21 September 2012. Flip Otto Dept. of Clinical Imaging Sciences UFS. Clinical information. 15 year old girl from Kimberly Problem list: Burkitts lymphoma/ leukemia ( bonemarrow biopsy confirmed Burkitt type blasts on immunophenotyping ) Thrombocytopaenia , anaemia

335 views • 16 slides

How I treat relapsed and refractory Hodgkin lymphoma

How I treat relapsed and refractory Hodgkin lymphoma. dr.kaji 1392. blood-2010-09-288373 Prepublished online January 24, 2011;. Introduction.

344 views • 16 slides

Author(s) Jennifer labas , FNP-BC, RN, MSN

575 views • 14 slides